Business · 25/08/2003Updated: 10/17/2026 · 1 min read
FDA Extends Comment Period for Over-the-Counter Antigingivitis/Antiplaque Drug Products
Summary
The Food and Drug Administration (FDA) is extending the comment period for proposed rulemaking on over-the-counter antigingivitis/antiplaque drug products until November 25, 2003, to allow more time for public input.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →